Biomedical Center Faculty of Medicine in Pilsen Charles University Pilsen Czechia

Institute of Biology and Medical Genetics 1st Faculty of Medicine Charles University Prague Czechia

Institute of Experimental Medicine Czech Academy of Sciences Prague Czechia

Institute of Medical Biometry and Informatics University of Heidelberg Heidelberg Germany

Editorial on the Research Topic Current understanding of genomic and chromosomal instabilities in solid malignancies PubMed

Zobrazit více v PubMed

Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell (2011) 144:646–73. doi: 10.1016/j.cell.2011.02.013 PubMed DOI

Senga SS, Grose RP. Hallmarks of cancer-the new testament. Open Biol (2021) 11:200358. doi: 10.1098/rsob.20.0358 PubMed DOI PMC

Tomasova K, Kroupa M, Forsti A, Vodicka P, Vodickova L. Telomere maintenance in interplay with DNA repair in pathogenesis and treatment of colorectal cancer. Mutagenesis (2020) 35(3):261–71. doi: 10.1093/mutage/geaa005 PubMed DOI

Vodicka P, Andera L, Opattova A, Vodickova L. The interaction of DNA repair, telomere homeostasis, and p53 mutational status in solid cancers: risk, prognosis and prediction. Cancers (Basel) (2021) 13(3):479. doi: 10.3390/cancers13030479 PubMed DOI PMC

Vodicka P, Vodenkova S, Opattova A, Vodickova L. DNA damage and repair measured by comet assay in cancer patients. Mutat Res Gen Tox En (2019) 843:95–110. doi: 10.1016/j.mrgentox.2019.05.009 PubMed DOI

Pearl LH, Schierz AC, Ward SE, Al-Lazikani B, Pearl FM. Therapeutic opportunities within the DNA damage response. Nat Rev Cancer (2015) 15:166–80. doi: 10.1038/nrc3891 PubMed DOI

Piemonte KM, Anstine LJ, Keri RA. Centrosome aberrations as drivers of chromosomal instability in breast cancer. Endocrinology (2021) 162(12):bqab208. doi: 10.1210/endocr/bqab208 PubMed DOI PMC

Sarkar S, Sahoo PK, Mahata S, Pal R, Ghosh D, Mistry T, et al. . Mitotic checkpoint defects: en route to cancer and drug resistance. Chromosome Res (2021) 29(2):131–44. doi: 10.1007/s10577-020-09646-x PubMed DOI

Srinivas N, Rachakonda S, Kumar R. Telomeres and telomere length: A general overview. Cancers (Basel) (2020) 12(3):558. doi: 10.3390/cancers12030558 PubMed DOI PMC

Heidenreich B, Kumar R. TERT promoter mutations in telomere biology. Mutat Res Rev Mutat Res (2017) 771:15–31. doi: 10.1016/j.mrrev.2016.11.002 PubMed DOI

Kroupa M, Rachakonda SK, Liska V, Srinivas N, Urbanova M, Jiraskova K, et al. . Relationship of telomere length in colorectal cancer patients with cancer phenotype and patient prognosis. Br J Cancer (2019) 121(4):344–50. doi: 10.1038/s41416-019-0525-3 PubMed DOI PMC

Hemminki K, Rachakonda S, Musak L, Vymetalkova V, Halasova E, Försti A, et al. . Telomere length in circulating lymphocytes: association with chromosomal aberrations. Genes Chromosomes Cancer (2015) 54(3):194–6. doi: 10.1002/gcc.22225 PubMed DOI

Wang H, Ni J, Guo X, Xue J, Wang X. Effects of folate on telomere length and chromosome stability of human fibroblasts and melanoma cells in vitro: A comparison of folic acid and 5-methyltetrahydrofolate. Mutagenesis (2023) 38(3):160–8. doi: 10.1093/mutage/gead007 PubMed DOI

Malki A, Elruz RA, Gupta I, Vallouch A, Vranic S, Al Moustafa A. Molecular mechanisms of colon cancer progression and metastasis: recent insights and advancements. Int J Mol Sci (2021) 22(1):2. doi: 10.3390/ijms22010130 PubMed DOI PMC